Previous Close | 501.59 |
Open | 502.62 |
Bid | 498.69 x 1300 |
Ask | 499.21 x 800 |
Day's Range | 496.51 - 504.57 |
52 Week Range | 475.77 - 609.85 |
Volume | |
Avg. Volume | 1,447,542 |
Market Cap | 191.636B |
Beta (5Y Monthly) | 0.77 |
PE Ratio (TTM) | 33.89 |
EPS (TTM) | 14.65 |
Earnings Date | Oct 24, 2023 - Oct 30, 2023 |
Forward Dividend & Yield | 1.40 (0.28%) |
Ex-Dividend Date | Sep 14, 2023 |
1y Target Est | 625.14 |
Subscribe to Yahoo Finance Plus to view Fair Value for TMO
Thermo Fisher Scientific (TMO) closed at $501.59 in the latest trading session, marking a -0.8% move from the prior day.
Investors have been buoyed this year by the fact that a mooted recession has failed to materialize. However, Morgan Stanley’s chief U.S. equity strategist, Mike Wilson, says that it does not mean the prospect of one taking place has completely evaporated. “While the investor sentiment pendulum on a recession arriving in 2023 has swung from roughly ’70/30′ to ’30/70′ over the past 6 months based on our dialogue, there is more debate on whether we have avoided it altogether – i.e., soft/no landing
Key Insights Institutions' substantial holdings in Thermo Fisher Scientific implies that they have significant...